Also known as Autologous Hematopoietic Cell Transplant, Autologous HCT, or Autologous BMT
"Auto" means "self." An autologous stem cell transplant uses healthy blood-forming stem cells from the patient. These cells are known as hematopoietic stem cells. Stem cells are made in the spongy part of bones, called bone marrow. They make all types of blood cells in the body.
An autologous transplant uses a patient’s own blood-forming cells (stem cells) to replace cells that have been damaged or destroyed by high doses of chemotherapy or radiation.
Before high-dose therapy begins, the patient donates their own healthy blood-forming stem cells. The cells are processed and frozen for later use. The patient then receives chemotherapy or radiation to treat their disease. After treatment, patients receive their own stem cells to replace those that were destroyed.
The stem cells travel to the bone marrow. They grow and make healthy blood cells, including red blood cells, platelets, and white blood cells.
Learn about transplants using donor cells from other people: allogeneic stem cell transplant.
Autologous transplants are used for certain cancers, including:
The autologous transplant process involves:
Patients receive their own cells, so there is no risk that the immune system will view the transplanted cells as foreign and attack or reject them.
Possible problems after autologous transplant include:
–
Reviewed: August 2022
An allogeneic stem cell (bone marrow) transplant replaces damaged blood-forming stem cells with healthy ones from a donor.
A stem cell transplant (bone marrow transplant) may be used as a treatment for some childhood cancers and blood disorders. Learn more about stem cell transplants.
Treatments for childhood illnesses include medicine, surgery, radiation, stem cell transplant, immunotherapy, or targeted therapy. Learn about these treatments.